MedWatch

Genome editing's front-runner on visit in Denmark: "CRISPR can fill in voids traditional drugs cannot treat."

The young researcher Feng Zhang, who develops the genome editing tool CRISPR to diagnose and treat diseases, believes that CRISPR is the key to treat several genetic diseases that have so far been incurable.

Foto: Ritzau Scanpix/AP Photo/Susan Walsh

Incurable genetic diseases might face one revolutionary treatment after the other in the near future.

This is according to the MIT- and Harvard-based researcher Feng Zhang, who is known for his work with developing the genome editing tool CRISPR as treatment of diseases. Wednesday this week, he visited Copenhagen.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier